» Articles » PMID: 22419273

Molecular Mapping of High-grade Cervical Intraepithelial Neoplasia Shows Etiological Dominance of HPV16

Overview
Journal Int J Cancer
Specialty Oncology
Date 2012 Mar 16
PMID 22419273
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Women with high-grade cervical intraepithelial neoplasia (HGCIN) frequently present with multiple cervical lesions and multiple concomitant Human papillomavirus (HPV) genotype infections. To elucidate HPV genotype attribution in different regions on the cervix, we performed molecular mapping of cervical disease in women with HGCIN. Thirteen subjects referred to colposcopy for abnormal cervical cancer screening results were included. A cervical smear and biopsies from 4 different areas on the cervix were collected. HPV genotyping using Linear Array (for cytology) or SPF(10) LiPA(25) (for histology) were performed in 13 smears, 52 whole sections from biopsies and 138 tissue regions isolated with laser capture microdissection (LCM). Twelve subjects had a diagnosis of CIN3 and one subject had a diagnosis of CIN2 based on the worst histology found in 4 biopsies. Eight of the 13 smears (62%) showed multiple genotype infections. Four of 13 women (31%) had multiple HPV infections in their biopsies. After performing LCM-PCR, only one woman (8%) had two different carcinogenic HPV types in morphologically distinct, but colliding HGCIN lesions. HPV16 was identified as the causal type in all women with HPV16 in cytology. A large proportion of other HPV types found in cervical smears were not detected at the tissue level. Using tissue-based genotyping and LCM-PCR analysis, we were able to attribute an individual HPV type to each area of CIN lesions. We demonstrate that HPV16 is even more etiologically dominant than previously thought, based on various genotype attribution models.

Citing Articles

Multiple high-risk HPV infections probably associated with a higher risk of low-grade cytological abnormalities but not with high-grade intraepithelial lesions of the cervix.

Tong T, Su D, Yang Q, Yang K, Liu Y, Wang Q World J Surg Oncol. 2024; 22(1):79.

PMID: 38486308 PMC: 10938671. DOI: 10.1186/s12957-024-03360-2.


Risk of cervical intraepithelial neoplasia grade 3 or more diagnoses for human papillomavirus16/18-positive women by cytology and co-infection status.

Ao M, Yao X, Zheng D, Gu X, Xi M Infect Agent Cancer. 2023; 18(1):57.

PMID: 37807070 PMC: 10561498. DOI: 10.1186/s13027-023-00540-9.


The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland.

Cuschieri K, Palmer T, Graham C, Cameron R, Roy K Br J Cancer. 2023; 129(7):1134-1141.

PMID: 37563221 PMC: 10539290. DOI: 10.1038/s41416-023-02386-9.


The role of multiple high-risk human papillomavirus infections for cervical biopsies and findings in colposcopic procedures.

Akis S, Ozturk U, Keles E, Alinca C, Kabaca C, Api M J Turk Ger Gynecol Assoc. 2023; 24(2):101-108.

PMID: 36992075 PMC: 10258572. DOI: 10.4274/jtgga.galenos.2023.2022-8-10.


Low-Grade Cervical Intraepithelial Neoplasia (CIN1) Evolution: Analysis of Opportunistic Preventive Vaccination Role.

Gardella B, Dominoni M, Pasquali M, Melito C, Fiandrino G, Cesari S Vaccines (Basel). 2023; 11(2).

PMID: 36851162 PMC: 9961273. DOI: 10.3390/vaccines11020284.


References
1.
Castle P, Rodriguez A, Porras C, Herrero R, Schiffman M, Gonzalez P . A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis. 2007; 34(11):849-55. PMC: 3962831. DOI: 10.1097/OLQ.0b013e318064c8c5. View

2.
van Doorn L, Quint W, Kleter B, Molijn A, Colau B, Martin M . Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol. 2002; 40(3):979-83. PMC: 120246. DOI: 10.1128/JCM.40.3.979-983.2002. View

3.
McCredie M, Sharples K, Paul C, Baranyai J, Medley G, Jones R . Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008; 9(5):425-34. DOI: 10.1016/S1470-2045(08)70103-7. View

4.
Bosch F, Lorincz A, Munoz N, Meijer C, Shah K . The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4):244-65. PMC: 1769629. DOI: 10.1136/jcp.55.4.244. View

5.
Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D . p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002; 26(11):1389-99. DOI: 10.1097/00000478-200211000-00001. View